Incidence of severe urinary tract infections not increased by initiating sodium–glucose cotransporter 2 inhibitors

First of all, high glycated hemoglobin might initially be a contributing factor. [...]a diabetes‐related condition that includes the duration of diabetes and the presence of microvascular complications is important. [...]identifying the presence of lower UTI at the baseline as a risk of developing s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of diabetes investigation 2020-05, Vol.11 (3), p.530-531
1. Verfasser:	Yokoyama, Hiroki
Format:	Artikel
Sprache:	eng
Schlagworte:	Bacteria Clinical trials Clinical Trials as Topic - methods Commentaries Diabetes Diabetes mellitus Glucose Health risk assessment Hemoglobin Humans Incidence Microvasculature Peptides Severity of Illness Index Sodium-Glucose Transporter 2 Inhibitors - adverse effects Sodium-Glucose Transporter 2 Inhibitors - therapeutic use Studies Urinary tract Urinary tract diseases Urinary tract infections Urinary Tract Infections - diagnosis Urinary Tract Infections - drug therapy Urinary Tract Infections - epidemiology Urogenital system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	First of all, high glycated hemoglobin might initially be a contributing factor. [...]a diabetes‐related condition that includes the duration of diabetes and the presence of microvascular complications is important. [...]identifying the presence of lower UTI at the baseline as a risk of developing severe upper UTI would be helpful.
ISSN:	2040-1116 2040-1124
DOI:	10.1111/jdi.13189